enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
3.390
+0.040 (1.19%)
Nov 4, 2024, 4:00 PM EST - Market closed

enVVeno Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-21.24-23.52-24.67-16.53-9.14-7.63
Upgrade
Depreciation & Amortization
0.540.550.530.450.380.4
Upgrade
Loss (Gain) From Sale of Assets
----0.03-
Upgrade
Asset Writedown & Restructuring Costs
-----0.59
Upgrade
Loss (Gain) From Sale of Investments
0-0.47-0.05---
Upgrade
Stock-Based Compensation
4.275.28.9960.880.94
Upgrade
Other Operating Activities
----0.31-0.21-
Upgrade
Change in Accounts Receivable
-----0.03
Upgrade
Change in Accounts Payable
0.13-0.220.09-0.830.170.14
Upgrade
Change in Other Net Operating Assets
-0.41-0.4-0.51-0.630.21-0.37
Upgrade
Operating Cash Flow
-16.71-18.86-15.62-11.85-7.68-5.9
Upgrade
Capital Expenditures
-0.04-0.03-0.12-0.37-0.18-0.36
Upgrade
Investment in Securities
-9.72-7.84-34.44---
Upgrade
Investing Cash Flow
-9.75-7.87-34.55-0.37-0.18-0.36
Upgrade
Short-Term Debt Issued
----0.31-
Upgrade
Total Debt Issued
----0.31-
Upgrade
Net Debt Issued (Repaid)
----0.31-
Upgrade
Issuance of Common Stock
39.4325.79-39.3313.46.57
Upgrade
Other Financing Activities
---18.27--0.94
Upgrade
Financing Cash Flow
39.4325.79-57.6115.075.64
Upgrade
Net Cash Flow
12.97-0.94-50.1745.397.22-0.62
Upgrade
Free Cash Flow
-16.74-18.89-15.73-12.22-7.86-6.26
Upgrade
Free Cash Flow Margin
------20037.42%
Upgrade
Free Cash Flow Per Share
-1.05-1.54-1.66-1.41-6.08-9.93
Upgrade
Cash Interest Paid
-----0
Upgrade
Levered Free Cash Flow
-8.91-10.37-6.33-5.82-3.77-3.41
Upgrade
Unlevered Free Cash Flow
-8.91-10.37-6.33-5.82-3.77-3.41
Upgrade
Change in Net Working Capital
-0.020.30.151.35-0.85-0.04
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.